The Institute

The California Institute for Biomedical Research (Calibr) is an independent, not-for-profit organization established to accelerate the translation of basic biomedical research to innovative new medicines.  Scientists at Calibr work together with investigators at other academic institutions and non-profit foundations to advance exciting research discoveries and technologies to new medicines for the treatment of human disease.

Tools & Capabilities

Calibr’s scientists have extensive drug discovery expertise and state-of-the-art drug discovery infrastructure including:

 

· uHTS  Automation & Technologies

· High Content Screening Platforms

· Medicinal Chemistry

· Protein Chemistry

· Pharmacology

· Chemical and Protein Libraries

 

We also have depth across a variety of platforms and modalities including:

 

· Protein Therapeutics

· Small Molecule Therapeutics

· Antibody Conjugates and Bi-Specifics

· Cell-Targeted Therapies

A Collaborative Focus

Calibr has ongoing scientific collaborations in cancer biology, degenerative diseases of aging and regenerative medicine, autoimmune, cardiovascular, and metabolic disease, as well programs focused on orphan and neglected disease.  We actively engage investigators with innovative new approaches to human therapeutics.

 

A Creative and Highly Integrated Approach

Calibr tightly integrates its broad drug discovery platforms and technologies, in-house expertise and academic collaborators to rapidly advance innovative new ideas toward the clinic.

 

Get in touch

© 2013 California Institute for Biomedical Research                                                                                                                                            info@calibr.org